These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35427081)

  • 21. Distinguishing normal and aggregated alpha-synuclein interaction on gold nanorod incorporated zinc oxide nanocomposite by electrochemical technique.
    Adam H; Gopinath SCB; Arshad MKM; Parmin NA; Hashim U
    Int J Biol Macromol; 2021 Feb; 171():217-224. PubMed ID: 33418041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay.
    Cariulo C; Martufi P; Verani M; Azzollini L; Bruni G; Weiss A; Deguire SM; Lashuel HA; Scaricamazza E; Sancesario GM; Schirinzi T; Mercuri NB; Sancesario G; Caricasole A; Petricca L
    Front Neurosci; 2019; 13():889. PubMed ID: 31507364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
    Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
    Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
    Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
    Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
    Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease biomarkers based on α-synuclein.
    Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological Analysis of Alpha-synuclein and NF-κB in Parkinson's Disease Patients.
    Gupta V; Garg RK; Khattri S
    J Clin Diagn Res; 2015 May; 9(5):BC01-4. PubMed ID: 26155470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
    Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu Y; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ
    Brain; 2019 Sep; 142(9):2845-2859. PubMed ID: 31312839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease.
    Shim KH; Go HG; Bae H; Jeong DE; Kim D; Youn YC; Kim S; An SSA; Kang MJ
    Front Aging Neurosci; 2021; 13():726525. PubMed ID: 34305578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.
    Abdullah R; Patil KS; Rosen B; Pal R; Prabhudesai S; Lee S; Basak I; Hoedt E; Yang P; Panick K; Ho HP; Chang E; Tzoulis C; Larsen JP; Neubert TA; Alves G; Møller SG
    Mol Neurobiol; 2017 Dec; 54(10):7639-7655. PubMed ID: 27837450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
    Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
    Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.
    Locascio JJ; Eberly S; Liao Z; Liu G; Hoesing AN; Duong K; Trisini-Lipsanopoulos A; Dhima K; Hung AY; Flaherty AW; Schwarzschild MA; Hayes MT; Wills AM; Shivraj Sohur U; Mejia NI; Selkoe DJ; Oakes D; Shoulson I; Dong X; Marek K; Zheng B; Ivinson A; Hyman BT; Growdon JH; Sudarsky LR; Schlossmacher MG; Ravina B; Scherzer CR
    Brain; 2015 Sep; 138(Pt 9):2659-71. PubMed ID: 26220939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.